United Kingdom· GB-APID-35464811000001108
Sucrose oral powder
A medicinal product containing sucrose, registered in United Kingdom by Special Order.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Sucrose
- Manufacturer
- Special Order
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5055225061003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sucrose in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Netherlands · Natterman Bronchicum
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7db1972-e7ef-4b7a-8c7d-f0464fe9522e GET /v1/drugs/d7db1972-e7ef-4b7a-8c7d-f0464fe9522e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "35464811000001108",
"desc": "Sucrose oral powder (Special Order)",
"form": "Oral powder",
"vpid": "35515011000001108",
"source": "dmd",
"vtm_id": "777624007",
"strength": "1 mg",
"substance": "Sucrose",
"ingredient": "Sucrose",
"supplier_code": "8286711000001104"
}See everything about sucrose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.